Latest research conducted by Headache Care Center in Springfield, Missouri has shown that injections of Botox (botulinum toxin) can help in preventing migraines in people suffering from migraine attacks frequently and have not benefited much from oral therapies for prevention. Patients treated with botox had fewer episodes of headache as compared to placebo-treated patients. Also, it fared better in the Headache Impact Test.

In late January, a consumer group called Public Citizen filed a petition with the FDA requesting labeling alterations for botulinum toxins (Botox(R)) or Myobloc(R)) marketed in the U.S. The American Society for Aesthetic Plastic Surgery (ASAPS), which is the sole plastic surgery organization devoted completely to the advancement of cosmetic surgery, said that “the safety references in the petition are already satisfactorily addressed in the manufacturer labeling with detailed information and guidance, including approved indications, contraindications, warnings, drug interactions, precautions, and reported adverse event information.”

The ASAPS added that the product is “safe and efficacious,” while recommending its continued use as indicated.